VEGFA and neoplasm: Although VEGF is the most potent proangiogenic protein described to date, with biologic effects relevant to tumor angiogenesis[20] and many clinical trials of VEGF-targeted therapy against advanced RCCs carried out,[21] the prognostic value is controversial in studies of its tissue[22–24] and serum[25] expression.